CINECA IRIS Institutional Research Information System

PIRRO, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.146
EU - Europa 1.835
AS - Asia 974
SA - Sud America 95
AF - Africa 19
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.127
IT - Italia 436
SG - Singapore 335
CN - Cina 319
DK - Danimarca 239
SE - Svezia 178
IE - Irlanda 171
DE - Germania 159
FR - Francia 149
UA - Ucraina 97
FI - Finlandia 90
BR - Brasile 80
IN - India 68
JP - Giappone 68
GB - Regno Unito 67
AT - Austria 64
KR - Corea 57
PL - Polonia 38
ES - Italia 33
HK - Hong Kong 24
VN - Vietnam 23
BE - Belgio 22
CZ - Repubblica Ceca 17
AU - Australia 15
NL - Olanda 14
TR - Turchia 14
ID - Indonesia 13
CA - Canada 11
GR - Grecia 10
RU - Federazione Russa 10
CH - Svizzera 8
IQ - Iraq 8
RS - Serbia 8
TW - Taiwan 8
PK - Pakistan 7
EG - Egitto 6
JO - Giordania 6
MX - Messico 6
RO - Romania 6
CL - Cile 5
IR - Iran 5
PT - Portogallo 5
SN - Senegal 5
DZ - Algeria 4
AR - Argentina 3
BG - Bulgaria 3
EC - Ecuador 3
LT - Lituania 3
MK - Macedonia 3
MY - Malesia 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
NZ - Nuova Zelanda 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 6.087
Salva come PNG Salva come JPEG
Città #
Ann Arbor 529
Chandler 437
Singapore 207
Beijing 171
Santa Clara 167
Dublin 161
Houston 136
Fairfield 131
Ashburn 105
Torino 104
Villeurbanne 94
Nyköping 80
Dearborn 78
Wilmington 74
Jacksonville 70
Woodbridge 67
Princeton 61
Vienna 59
Columbus 54
Medford 54
Redwood City 50
Cambridge 49
Seattle 49
Turin 35
Fremont 32
New York 28
Pisa 28
Warsaw 27
Milan 26
Boston 24
Hong Kong 22
Guangzhou 21
Hefei 20
Düsseldorf 18
Boardman 17
Munich 17
Brussels 16
Dong Ket 16
Brno 13
London 13
Los Angeles 13
Mumbai 13
Nanjing 13
Florence 12
San Diego 12
Shanghai 12
São Paulo 11
Tokyo 11
Helsinki 10
Jakarta 10
West Jordan 10
Würzburg 10
Cork 8
Nuremberg 8
Paris 8
Belgrade 7
Falkenstein 7
Rome 7
Shenzhen 7
Valencia 7
Cuneo 6
Hyderabad 6
Jinan 6
Kunming 6
Nanchang 6
Piemonte 6
Bangalore 5
Catania 5
Fürstenzell 5
Madrid 5
New Delhi 5
Norwalk 5
Phoenix 5
Taipei 5
Toronto 5
Verona 5
Washington 5
Zurich 5
Baghdad 4
Esslingen am Neckar 4
Falls Church 4
Hangzhou 4
Istanbul 4
Komancza 4
Kumar 4
Nottingham 4
Philadelphia 4
Pune 4
Siena 4
Tianjin 4
Amman 3
Anghiari 3
Atlanta 3
Bari 3
Belo Horizonte 3
Bobrowniki Male 3
Boulder 3
Cardenal 3
Copenhagen 3
Dallas 3
Totale 3.730
Salva come PNG Salva come JPEG
Nome #
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 454
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 439
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 417
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 212
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 201
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 185
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 177
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 172
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 172
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 168
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 164
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration 156
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 151
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 149
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 144
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 140
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 134
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 131
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions 128
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 117
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 110
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 110
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 109
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 100
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 94
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 91
Clinical relevance of deferasirox trough levels in β-thalassemia patients 88
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 88
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 84
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 83
Salicylic acid inhibits dimethylbenzanthracene (DMBA) induced mammary carcinogenesis in a dose dipendent manner 81
Evaluating the impact of angiogenetic inhibitors on chemical carcinogenesis of oral tumors in the buccal pouch Syrian hamster model 80
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 80
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 80
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 80
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 79
Antineoplastic effects of SU5416, a novel vascular endothelial growth factor pathway inhibitor, in an oral cancer model 77
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 76
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma 75
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 75
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 74
Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration 65
Salicylate counteracts streptozotocin induced diabetes mellitus in rat 63
New HPLC MS method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib and nilotinib. 60
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 53
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 49
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients 46
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 42
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib in chronic myeloid leukaemia patients 38
Evaluation of the control of pain in patients with bone metastasis undergoing medical treatment with bisphosphonates 24
The importance of monitoring circulating mitotane levels in the management of adrenocortical cancer patients 22
Evaluation of nausea and vomiting in oncology patients treated with chemotherapy: a retrospective study 21
VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS 13
Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome. A case report 13
Il ritmo sonno-veglia nel paziente sottoposto a chemioterapia: uno studio retrospettivo [Sleep-wake cycle in chemotherapy patients: a retrospective study] 9
Totale 6.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.356
article - articoli 0
book - libri 0
conference - conferenze 7.064
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 0 0 0 0 78 100
2020/2021613 85 41 35 39 53 49 32 23 73 35 70 78
2021/20221.013 69 65 68 84 53 90 94 65 42 46 192 145
2022/20231.113 114 123 65 124 84 252 53 76 107 29 64 22
2023/2024393 46 59 26 16 27 47 8 22 13 36 34 59
2024/2025933 28 56 46 113 292 76 32 58 136 73 23 0
Totale 6.343